from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3631/-

LFCtreatmentdescriptionclass of inhibitor

0.443

Amikacinug/mL Amikacintranslation

-0.103

Cap5-10ug/mL Capreomycintranslation

-0.826

Rox10-50 ug/mL Roxithromycintranslation

0.699

SM2-5 ug/mL Streptomycintranslation

2.357

Tet5-10 ug/mL Tetracyclinetranslation

0.919

Rif0.2-5ug/mL Rifampicintranscription

0.521

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.607

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.762

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.434

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.950

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.733

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.337

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.283

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.901

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.979

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.051

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.078

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.494

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.084

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.430

KCN5-20 ug/mL Potassium cyaniderespiration

0.075

NaN30.2-2 mM Sodium aziderespiration

0.070

Nigericin50 uM Nigericinrespiration

-0.385

TRC10-150 ug/mL Triclosanrespiration

-1.780

TRZ10-25 ug/mL Thioridazinerespiration

-1.753

Valinomycin0.5-10 uM Valinomycinrespiration

0.815

ZnSO42 mM ZnSO4respiration

-0.819

menadione6-10 ug/mL Menadionerespiration

0.238

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.188

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.222

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.229

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.345

NRP_1Non-replicating persistence stage 1dosRassociated

0.820

Amp0.2mg/mL AmpicillincellWall

0.267

Cephalexin20-100 ug/mL CephalexincellWall

-0.056

Cerulenin0.32-5 ug/mL CerulenincellWall

0.943

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.583

EMB10-20 ug/mL EthambutolcellWall

0.827

Eta12-40 ug/mL EthionamidecellWall

1.020

INH0.2-0.4 ug/mL IsoniazidcellWall

0.515

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.149

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.641

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.134

BZA0.12 mg/mL BenzamidearomaticAmides

-0.476

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.020

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.610

H2O24 mM hydrogen peroxideDNAdamaging

0.545

Levo10 ug/mL LevofloxacinDNAdamaging

0.772

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.355

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.107

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.623

UVUV-irradiationDNAdamaging

-0.926

ARP41-4 ug/mL Antitubercular compound ARP4?

0.192

Antimycin12.5-50 ug/mL Antimycin A?

0.053

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.156

PA_110-50 ug/mL Antitubercular compound PA-1?

0.886

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.790

PA8240.2-2 ug/mL PA-824?

-1.243

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.130

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.028

Verapamil50 uM Verapamil?

0.015

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.425

methoxatin10-20 ug/mL Methoxatin?